VARDENAFIL Drug Patent Profile

When do Vardenafil patents expire, and when can generic versions of Vardenafil launch?

Vardenafil is a drug marketed by Alembic, Macleods Pharms Ltd, Crossmedika Sa, Stevens J, Teva Pharms, and Zydus Pharms. and is included in eight NDAs.

The generic ingredient in VARDENAFIL is vardenafil hydrochloride. There are six drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the vardenafil hydrochloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Vardenafil

A generic version of VARDENAFIL was approved as vardenafil hydrochloride by TEVA PHARMS on May 3^rd, 2012.

Summary for VARDENAFIL

US Patents:	0
Applicants:	6
NDAs:	8
Drug Prices:	Drug price information for VARDENAFIL
DailyMed Link:	VARDENAFIL at DailyMed

See drug prices for VARDENAFIL

US Patents and Regulatory Information for VARDENAFIL

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Alembic	VARDENAFIL HYDROCHLORIDE	vardenafil hydrochloride	TABLET, ORALLY DISINTEGRATING;ORAL	208324-001	Nov 16, 2018	AB	RX	No	Yes
Teva Pharms	VARDENAFIL HYDROCHLORIDE	vardenafil hydrochloride	TABLET;ORAL	091347-001	May 3, 2012	AB	RX	No	No
Zydus Pharms	VARDENAFIL HYDROCHLORIDE	vardenafil hydrochloride	TABLET;ORAL	208960-003	Oct 31, 2018	AB	RX	No	No
Crossmedika Sa	VARDENAFIL HYDROCHLORIDE	vardenafil hydrochloride	TABLET;ORAL	209057-001	Oct 31, 2018	AB	RX	No	No
Alembic	VARDENAFIL HYDROCHLORIDE	vardenafil hydrochloride	TABLET;ORAL	214031-002	Aug 4, 2020	AB	RX	No	No
Macleods Pharms Ltd	VARDENAFIL HYDROCHLORIDE	vardenafil hydrochloride	TABLET;ORAL	204632-002	Oct 22, 2019	AB	RX	No	No